Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
Body fluids often contain freely circulating nucleic acids, many of which can be exploited as noninvasive tools for the diagnosis of cancer as well as for clinical prognostication. Identifying microRNAs (miRNAs) in subjects’ blood with various malignancies means that they can serve as novel biomarke...
Saved in:
Main Authors: | Wei Jin, Xiang Fei, Xia Wang, Fangjie Chen, Yan Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/5873056 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2020-06-01) -
The effect of systemic hypertension on prostatic arterial hemodynamics in dogs with benign prostate hyperplasia
by: Çağatay ESİN
Published: (2024-11-01) -
Use of miRNAs as Biomarkers in Sepsis
by: Raluca Dumache, et al.
Published: (2015-01-01) -
Predictive Model for Estimating Prostate Resection Size in Transurethral Resection of the Prostate for Patients with Benign Prostatic Hyperplasia
by: Okwudli C. Amu, et al.
Published: (2024-07-01) -
Impact of Benign Prostatic Hyperplasia Pharmacological Treatment on Transrectal Prostate Biopsy Adverse Effects
by: Marina Zamuner, et al.
Published: (2014-01-01)